Publicaciones (21) Publicaciones de ALBA ANGELINA QUERENCIAS

2024

  1. Deciphering the factors determining the differentiation of autoreactive thymocytes into regulatory T cells

    Allergy: European Journal of Allergy and Clinical Immunology

  2. The Role of Regulatory T Cells in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2024

    International Archives of Allergy and Immunology

2023

  1. A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells

    Cellular and Molecular Immunology, Vol. 20, Núm. 12, pp. 1499-1512

  2. C-Type Lectin Receptor Mediated Modulation of T2 Immune Responses to Allergens

    Current Allergy and Asthma Reports, Vol. 23, Núm. 3, pp. 141-151

  3. Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation

    Frontiers in Immunology, Vol. 14

  4. From trained immunity in allergy to trained immunity-based allergen vaccines

    Clinical and Experimental Allergy, Vol. 53, Núm. 2, pp. 145-155

2022

  1. Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring

    Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 1, pp. 212-222.e9

  2. Candida albicans V132 induces trained immunity and enhances the responses triggered by the polybacterial vaccine MV140 for genitourinary tract infections

    Frontiers in Immunology, Vol. 13

  3. Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells

    Clinical and Experimental Allergy, Vol. 52, Núm. 4, pp. 540-549

  4. Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming

    Mucosal Immunology, Vol. 15, Núm. 1, pp. 96-108

  5. Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 8, pp. 2337-2354

  6. Mechanismen bei AIT: Erkenntnisse 2021

    Allergologie, Vol. 45, Núm. 12, pp. 848-856

  7. The cannabinoid WIN55212-2 suppresses effector T-cell responses and promotes regulatory T cells in human tonsils

    Allergy: European Journal of Allergy and Clinical Immunology

2021

  1. Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 114-130

  2. The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption

    Allergy: European Journal of Allergy and Clinical Immunology

2020

  1. The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020

    International Archives of Allergy and Immunology, Vol. 181, Núm. 8, pp. 565-584

2019

  1. Ascaris lumbricoides cystatin prevents development of allergic airway inflammation in a mouse model

    Frontiers in Immunology, Vol. 10, Núm. SEP

2018

  1. Development of a Fluorescent Bodipy Probe for Visualization of the Serotonin 5-HT 1A Receptor in Native Cells of the Immune System

    Bioconjugate Chemistry, Vol. 29, Núm. 6, pp. 2021-2027

  2. A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells

    Bioconjugate Chemistry, Vol. 29, Núm. 2, pp. 382-389

  3. Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 875-884